Four Seas Pharma's Zongyan Receives NMPA Approval for Five New Specifications Today
According to Four Seas Pharma (00460) announcement today (October 5), its subsidiary Meiyan Space has received approval from China's National Medical Products Administration (NMPA) for five new specifications of hyaluronic acid complex solution (Zongyan).
The newly approved specifications are 0.75m
SIHUAN PHARM1.43%
GateNews·10-05 09:11
